13D/13G Filings - CERO THERAPEUTICS HOLDINGS INC. (CERO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-07
5:21 pm
Purchase
2025-02-0713DCERo Therapeutics Holdings, Inc.
CERO
Brian G. Atwood202,404
6.700%
5,081increase
(+2.57%)
Filing
History
2024-12-17
7:26 pm
Sale
2024-12-1313GCERo Therapeutics Holdings, Inc.
CERO
YK Bioventures Opportunities GP I, LLC170
0.000%
-226,038decrease
(-99.92%)
Filing
History
2024-12-13
7:18 pm
Purchase
2024-12-1013GMerida Merger Corp. I
MCMJ
Corey Lawrence8,529,316
5.700%
8,529,316increase
(New Position)
Filing
History
2024-11-20
4:06 pm
Purchase
2024-09-2413GCERo Therapeutics Holdings, Inc.
CERO
SLOAN STUART M210,680
14.000%
200,713increase
(+2013.84%)
Filing
History
2024-11-20
4:01 pm
Purchase
2024-02-1413GCERo Therapeutics Holdings, Inc.
CERO
SLOAN STUART M9,967
6.700%
9,967increase
(New Position)
Filing
History
2024-11-14
8:18 pm
Purchase
2024-08-0213GCERo Therapeutics Holdings, Inc.
CERO
YK Bioventures Opportunities GP I, LLC226,208
15.000%
226,208increase
(New Position)
Filing
History
2024-10-30
8:58 pm
Purchase
2024-09-2513DCERo Therapeutics Holdings, Inc.
CERO
Brian G. Atwood197,323
13.400%
197,323increase
(New Position)
Filing
History
2024-02-22
09:06 am
Sale
2023-12-3113GCERo Therapeutics Holdings, Inc.
CERO
Shaolin Capital Management LLC0
0.000%
-7,483decrease
(Position Closed)
Filing
History
2024-02-20
5:18 pm
Sale
2024-02-1413DCERo Therapeutics Holdings, Inc.
CERO
PHOENIX BIOTECH SPONSOR LLC10,150
6.800%
-42,812decrease
(-80.84%)
Filing
History
2024-02-08
12:31 pm
Sale
2023-12-3113GCERo Therapeutics Holdings, Inc.
CERO
Saba Capital Management, L.P.0
0.000%
-12,124decrease
(Position Closed)
Filing
History
2023-02-14
3:45 pm
Unchanged
2022-12-3013GCERo Therapeutics Holdings, Inc.
CERO
GOLDMAN SACHS GROUP INC
GS
0
0.000%
0
(Unchanged)
Filing
History
2023-02-14
1:51 pm
Sale
2022-12-3113GCERo Therapeutics Holdings, Inc.
CERO
Beryl Capital Management LLC0
0.000%
-12,303decrease
(Position Closed)
Filing
History
2023-02-14
06:39 am
Purchase
2022-12-3113GCERo Therapeutics Holdings, Inc.
CERO
Saba Capital Management, L.P.12,124
6.600%
2,550increase
(+26.63%)
Filing
History
2023-02-13
8:05 pm
Purchase
2022-12-3113GCERo Therapeutics Holdings, Inc.
CERO
Shaolin Capital Management LLC7,483
6.580%
7,483increase
(New Position)
Filing
History
2023-02-13
5:21 pm
Purchase
2022-12-3013GBiotech Acquisition Company
BIOT
GOLDMAN SACHS GROUP INC
GS
250,525
1.100%
250,525increase
(New Position)
Filing
History
2023-01-31
6:40 pm
Unchanged
2023-01-2713DCERo Therapeutics Holdings, Inc.
CERO
PHOENIX BIOTECH SPONSOR LLC52,962
78.200%
0
(Unchanged)
Filing
History
2023-01-25
07:24 am
Sale
2022-12-3113GCERo Therapeutics Holdings, Inc.
CERO
Highbridge Capital Management, LLC0
0.000%
-10,378decrease
(Position Closed)
Filing
History
2022-05-06
4:53 pm
Purchase
2022-04-2813GCERo Therapeutics Holdings, Inc.
CERO
Saba Capital Management, L.P.9,574
5.200%
9,574increase
(New Position)
Filing
History
2022-02-14
4:47 pm
Unchanged
2021-12-3113GPhoenix Biotech Acquisition Corp.
PBAXU
CANTOR FITZGERALD SECURITIES905,000
4.900%
0
(Unchanged)
Filing
History
2022-02-11
4:41 pm
Purchase
2021-12-3113GCERo Therapeutics Holdings, Inc.
CERO
Beryl Capital Management LLC12,303
6.700%
12,303increase
(New Position)
Filing
History
Goto 0, 1, Next